Our People

Academic Staff
​Prof. Vincent Chi-ho CHUNG 鍾志豪教授

Prof. Vincent Chi-ho CHUNG


B Chin Med, BSc Biomed Sci (HKBU), MSc Evid Based Healthcare (Oxford),

PhD Public Health (CUHK)

Associate Professor

Email: vchung@cuhk.edu.hk


ORCID: 0000-0002-5947-4492

Scopus Author ID: 868559460

ResearcherID: K-2447-2013

Academic Appointments

  • Head of Development Division, School of Chinese Medicine, The Chinese University of Hong Kong

  • Convener (Education) of the Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong

  • US National Academy of Medicine (NAM) International Health Policy Fellow (2021-2023)

  • Hong Kong Health and Medical Research Fund Research Fellow (2019-2021)

  • Chair of Research Advisory Committee (2021-2023) and Elected Member of Board of Directors (2018-2021), International Society for Traditional, Complementary and Integrative Medicine Research

  • Visiting Professor, Chengdu University of Traditional Chinese Medicine Hospital (2019-2022)

  • Visiting Associate Professor, School of Biological Sciences, Nanyang Technological University, Singapore (2020-2021)

  • Council Member of the Evidence based Healthcare Committee, Chinese Association of Integrative Medicine (2018-2020)

  • Visiting Research Fellow, Australian Research Centre in Complementary and Integrative Medicine, University Technology Sydney, Australia (2014-2020)


Dr. Vincent CH Chung is a registered Chinese medicine practitioner with training in both evidence based healthcare and public health. As a Jockey Club Scholar he received Bachelor of Chinese Medicine and Bachelor of Biomedical Science (First Class) from Hong Kong Baptist University. With support from the Li Po Chun Charitable Trust Fund – Overseas Postgraduate Study and Professional Training Scholarship, he completed his MSc in Evidence based Healthcare in Oxford University. He studied his PhD in Public Health at The Chinese University of Hong Kong, focusing on health services research.


He is one of the few scholars with research spanning across clinical, public health, and policy aspects of Integrative Medicine. He envisions evidence-based integration of conventional and complementary healthcare by promoting rigorous research, policy advocacy, and quality education locally, nationally, and internationally. He has published more than 133 articles in international peer-reviewed academic journals including the Canadian Medical Association Journal (IF: 8.26), Cochrane Database of Systematic Reviews (IF: 9.28), Annals of the Rheumatic Diseases (IF:19.1), Obesity Reviews (IF: 9.21), Perspectives in Public Health (Top 10% journal in the Public, Environmental & Occupational Health Category, IF: 4.94), Journal of Ethnopharmacology and Chinese Medicine (Top journals in the Integrative and Complementary Medicine Category, IF: 4.36 and 5.45 respectively).


He ranked at the top 1.84% amongst all researchers in the category of Complementary & Alternative Medicine globally, according to the updated science-wide author databases of standardized citation indicators (PloS Biology 18.10 (2020): e3000918). He served as a consultant for the WHO Western Pacific Regional Office in formulating strategy for using traditional and complementary medicine for promoting healthy aging, as well as an observer in the development process of WHO Traditional Medicine Strategy. Consultancy reports are published in British Medical Bulletin 137.1 (2021): 70-81 and Integrative Medicine Research 10.1 (2021): 100469.


He was the Principal Investigator of 10 external competitive research grants (5 from the Health and Medical Research Fund, 2 from Chinese Medicine Development Fund, 3 from commissioned research grants and research contracts). He has supervised / co-supervised 3 PhD students to completion and has contributed to 3 book chapters. He is Associate Editor of BMC Trials (Since 2019), BMC Complementary Medicine and Therapies (Since 2011) and Complementary Therapies in Medicine (2017-2020), and serves as editorial board member of European Journal of Integrative Medicine (Since 2013) and Scientific Reports (2017-2019).


He serves as External Examiner of the BSc Chinese Medicine program for the International Medical University, Malaysia (2021-2023). He has been an External Assessor (for promotion and substantiation) in Public Health for University Technology Sydney, and in Chinese Medicine for Western Sydney University, Australia. He reviewed grants for both international and local research funding bodies including EU / MSCA-Cofund doctoral program of the Swiss School of Public Health (SSPH+), Research and Development Administration Office of the University of Macau, and the Hong Kong Research Grants Council. He was appointed as External Examiner for PhD candidates at Western Sydney University.


On public and government services, he serves as a member of the Hong Kong SAR Government Chinese Medicine Development Committee (2018-2023), as well as the Patient Experience Sub-committee of the Chinese Medicine Hospital Planning Office. He was also a member of the Registration Committee, Chinese Medicine Practitioner Board, Chinese Medicine Council of Hong Kong (2018-2021).

Research Interests

  • Evidence based healthcare

  • Randomized controlled trials

  • Policy and Implementation Research in Integrative Medicine

Recent Funded Research Projects 

  • Influence from the use of syndrome differentiation on treatment effect estimates in Chinese herbal medicine trials: meta-epidemiological study and network meta-analysis (Chinese Medicine Development Fund)

  • Complex interventions for reducing 30-day avoidable hospital readmission among adults: recommendations for Hong Kong via overview of systematic reviews and stakeholder consensus (Health and Medical Research Fund)

  • Theory-based Development of Implementation Interventions to Scale-up Adoption or Enhancement of Integrated Chinese-Western Medicine Services for Cancer Palliative Care (Chinese Medicine Development Fund)

  • Identifying Priority Research Questions for Addressing Unmet Cancer Palliative Care Needs Using Chinese Medicine with a Systematic Approach (Health and Medical Research Fund)

  • Data Driven Identification and Classification of Chinese Medicine Syndrome Types among Functional Dyspepsia Patients: Latent Tree Analysis (Health and Medical Research Fund Fellowship Scheme)

  • Electroacupuncture plus Standard Care for Managing Refractory Functional Dyspepsia: Pragmatic Randomized Trial with Economic Evaluation (Health and Medical Research Fund)

  • Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial Primary Care Setting (Health and Medical Research Fund)

Selected Publications

  1. Ho, L. T., Zhong, C. C., Wong, C. H., Wu, J. C., Chan, K. K., Wu, I. X., ... & Chung, V. C. (2021). Herbal medicine for functional dyspepsia: Network meta-analysis of placebo-controlled randomised trials. Journal of Ethnopharmacology, 114665.

  2. Zhong, C. C. W., Wong, C. H. L., Cheung, W. K. W., Yeoh, E. K., Hung, C. T., Yip, B. H. K., ... & Chung, V. C. (2021). Peri-discharge complex interventions for reducing 30-day hospital readmissions among heart failure patients: overview of systematic reviews and network meta-analysis. Perspectives in Public Health, 1757913920985258.

  3. Chung, V. C., Ho, L. T., Leung, T. H., & Wong, C. H. (2021). Designing delivery models of traditional and complementary medicine services: a review of international experiences. British Medical Bulletin, 137(1), 70-81.

  4. Ho, L., Ke, F. Y., Wong, C. H., Wu, I. X., Cheung, A. K., Mao, C., & Chung, V. C. (2021). Low methodological quality of systematic reviews on acupuncture: a cross-sectional study. BMC Medical Research Methodology, 21(1), 1-11.

  5. Li, Z. H., Gao, X., Chung, V. C., Zhong, W. F., Fu, Q., Lv, Y. B., ... & Mao, C. (2020). Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Annals of the Rheumatic Diseases, 79(6), 829-836.

  6. Wong, C. H., Wu, I. X., Adams, J., Steel, A., Wardle, J., Wu, J. C., ... & Chung, V. C. (2020). Development of Evidence-Based Chinese Medicine Clinical Service Recommendations for Cancer Palliative Care Using Delphi Approach Based on the Evidence to Decision Framework. Integrative Cancer Therapies, 19, 1534735420940418.

  7. Wong, C. H., Wu, I. X., Balneaves, L. G., Lo, R. S., Witt, C. M., Wu, J. C., ... & Chung, V. C. (2019). Prioritizing Chinese Medicine Clinical Research Questions in Cancer Palliative Care: International Delphi Survey. Journal of Pain and Symptom Management, 58(6), 1002-1014.

  8. Chung, V. C., Wong, C. H., Wu, I. X., Ching, J. Y., Cheung, W. K., Yip, B. H., ... & Wu, J. C. (2019). Electroacupuncture plus on‐demand gastrocaine for refractory functional dyspepsia: Pragmatic randomized trial. Journal of Gastroenterology and Hepatology, 34(12), 2077-2085.

  9. Wu, I. X. Y., Kee, J. C. Y., Threapleton, D. E., Ma, R. C. W., Lam, V. C. K., Lee, E. K. P., ... & Chung, V. C. (2018). Effectiveness of smartphone technologies on glycaemic control in patients with type 2 diabetes: systematic review with meta‐analysis of 17 trials. Obesity Reviews, 19(6), 825-838.

  10. Chung, V. C., Ho, R. S., Liu, S., Chong, M. K., Leung, A. W., Yip, B. H., ... & Lau, A. Y. (2016). Electroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trial. Canadian Medical Association Journal, 188(12), 867-875.

Last Updated: 12 November 2021